These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33870589)

  • 1. Clinicopathological characteristics and prognosis of uterine serous carcinoma: A SEER program analysis of 1016 cases.
    Han Y; Liu C
    J Obstet Gynaecol Res; 2021 Jul; 47(7):2460-2472. PubMed ID: 33870589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive lymphadenectomy and survival prediction in uterine serous cancer patients after surgery: A population-based analysis.
    Li H; Xie X; Liu Y; Huang X; Lin H; Li J; Lin Z
    Eur J Surg Oncol; 2020 Jul; 46(7):1339-1346. PubMed ID: 32402510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of combined radiation and chemotherapy on outcome in uterine papillary serous carcinoma compared to chemotherapy alone.
    Mahdi H; Nutter B; Abdul-Karim F; Amarnath S; Rose PG
    J Gynecol Oncol; 2016 Mar; 27(2):e19. PubMed ID: 26463437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy in patients with stage IVB uterine serous carcinoma: a Turkish multicentric study.
    Unsal M; Kilic C; Cakir C; Kilic F; Ersak B; Karakas S; Tokgozoglu N; Varli B; Oktar O; Kimyon Comert G; Ozdemir IA; Boran N; Toptas T; Ureyen I; Korkmaz V; Taskin S; Moraloglu Tekin O; Ustun Y; Tasci T; Ortac F; Turan T
    J Obstet Gynaecol; 2023 Dec; 43(1):2151355. PubMed ID: 36503383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head & neck acinar cell carcinoma: a population-based study using the seer registry.
    Yibulayin F; Feng L; Wang M; Lu MM; Luo Y; Liu H; Yang ZC; Wushou A
    BMC Cancer; 2020 Jul; 20(1):631. PubMed ID: 32641007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of adjuvant therapy on the prognosis of ductal carcinoma of the major salivary gland: a large-scale cohort study.
    Zhang D; Li L; Wen T; Ma F
    Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):409-417. PubMed ID: 36036273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological characteristics and survival outcomes in patients with angiosarcoma of breast.
    Li J; Li Y; Wang Y; Li Z; Zhang H; Gao Y; Tan J
    Cancer Med; 2023 Jun; 12(12):13397-13407. PubMed ID: 37143261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Adjuvant Management Strategies on Outcomes in Women With Early Stage Uterine Serous Carcinoma.
    Cook A; Khalil R; Burmeister C; Dimitrova I; Elshaikh MA
    Cureus; 2021 Feb; 13(2):e13505. PubMed ID: 33786214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics, treatment and prognosis of oral adenocarcinoma: a population-based study.
    Wang Y; Wang S; Qu Y; Yang Y
    Eur Arch Otorhinolaryngol; 2023 Jul; 280(7):3365-3374. PubMed ID: 36892615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and Prognosis of Primary Head and Neck Angiosarcomas: A Surveillance, Epidemiology, and End Results Program (SEER) Analysis of 1250 Cases.
    Lee KC; Chuang SK; Philipone EM; Peters SM
    Head Neck Pathol; 2019 Sep; 13(3):378-385. PubMed ID: 30357539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcomes and patterns of failure in women with stage IIIC
    Lee JK; Mahan M; Hanna RK; Elshaikh MA
    Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():192-197. PubMed ID: 28800504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of tumor size with other prognostic factors in uterine serous carcinoma: a large multi-institutional study.
    Winer I; Mahdi H; Bandyopadhyay S; Semaan A; Van de Vijver KK; Nucci MR; Abdul-Karim F; Hussein Y; Qureshi F; Hayek K; Alosh B; Schulz D; Cote M; Munkarah A; Morris R; Oliva E; Ali-Fehmi R
    Gynecol Oncol; 2013 Feb; 128(2):316-21. PubMed ID: 23138135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel model to predict cancer-specific survival in patients with early-stage uterine papillary serous carcinoma (UPSC).
    Chen L; Liu X; Li M; Wang S; Zhou H; Liu L; Cheng X
    Cancer Med; 2020 Feb; 9(3):988-998. PubMed ID: 31846222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy.
    Tate K; Yoshida H; Ishikawa M; Uehara T; Ikeda SI; Hiraoka N; Kato T
    J Gynecol Oncol; 2018 May; 29(3):e34. PubMed ID: 29533019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic indicators of survival in sinonasal extranodal natural killer/T-cell lymphoma.
    Varelas AN; Ganti A; Eggerstedt M; Tajudeen BA
    Laryngoscope; 2019 Dec; 129(12):2675-2680. PubMed ID: 30801751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.
    Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O
    Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors prognostic of survival in advanced-stage uterine serous carcinoma.
    Holman LL; Pal N; Iglesias DA; Soliman PT; Balakrishnan N; Klopp A; Broaddus RR; Fleming ND; Munsell MF; Lu KH; Westin SN
    Gynecol Oncol; 2017 Jul; 146(1):27-33. PubMed ID: 28465008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological characteristics, survival outcomes and prognostic factors in pleomorphic carcinoma: a SEER population-based study.
    Chen Z; Liu J; Min L
    BMC Pulm Med; 2022 Mar; 22(1):116. PubMed ID: 35361152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas.
    Ayeni TA; Bakkum-Gamez JN; Mariani A; McGree ME; Weaver AL; Haddock MG; Keeney GL; Long HJ; Dowdy SC; Podratz KC
    Gynecol Oncol; 2013 Jun; 129(3):478-85. PubMed ID: 23535279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The demographic features, clinicopathologic characteristics, treatment outcome and disease-specific prognostic factors of solitary fibrous tumor: a population-based analysis.
    Wushou A; Jiang YZ; Liu YR; Shao ZM
    Oncotarget; 2015 Dec; 6(39):41875-83. PubMed ID: 26496033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.